Aurobindo Pharma has confirmed that the details of securities dematerialized or rematerialized during the quarter ended September 30, 2025, have been furnished to all relevant stock exchanges. Confirmation letters from their Registrar and Transfer Agent, KFin Technologies Limited, dated October 2, 2025, have been provided. The company confirms that all dematerialized securities are listed on the stock exchanges.
Compliance Update
Aurobindo Pharma has issued a certificate regarding the dematerialization and rematerialization of securities for Q2 2025 (July-September). This certificate confirms compliance with requirements related to depositories and participants.
Details of Compliance
The company states that all details pertaining to the dematerialization or rematerialization of securities during the quarter ending September 30, 2025, have been duly furnished to all stock exchanges where Aurobindo Pharma’s shares are listed.
Confirmation from Registrar
Aurobindo Pharma has enclosed letters from their Registrar and Transfer Agent (RTA), M/s. KFin Technologies Limited, dated October 2, 2025, as confirmation of the fulfilled requirements. Additionally, the company confirms that all dematerialized securities are listed on the relevant stock exchanges.
Source: BSE
